MICEST: A potential tool for non-invasive detection of molecular changes in Alzheimer's disease

Journal of Neuroscience Methods

Volumn 212, Issue 1, 2013, Pages 87-93

  Haris, Mohammad ^a   Singh, Anup ^a   Cai, Kejia ^a   Nath, Kavindra ^b   Crescenzi, Rachelle ^a   Kogan, Feliks ^a   Hariharan, Hari ^a   Reddy, Ravinder ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Chemical exchange saturation transfer imaging; Glial cells proliferation; Magnetic resonance spectroscopy; Myo inositol

Indexed keywords

INOSITOL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; CELL PROLIFERATION; CHEMICAL EXCHANGE SATURATION TRANSFER TECHNIQUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLIA CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN MAPPING; CHOLINE; CREATINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, TRANSGENIC; NEUROIMAGING; PRESENILIN-1; TRITIUM;

EID: 84867742280     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2012.09.025     Document Type: Article

References (25)

1. Aschner M., Allen J.W., Kimelberg H.K., LoPachin R.M., Streit W.J. Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 1999, 39:151-173.
2. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., et al. In vivo measurement of activated microglia in dementia. Lancet 2001, 358:461-467.
3. Chen C.J., Ou Y.C., Lin S.Y., Raung S.L., Liao S.L., Lai C.Y., et al. Glial activation involvement in neuronal death by Japanese encephalitis virus infection. J Gen Virol 2010, 91:1028-1037.
4. Chen S.Q., Wang P.J., Ten G.J., Zhan W., Li M.H., Zang F.C. Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dement Geriatr Cogn Disord 2009, 28:558-566.
5. Hammoud D.A., Endres C.J., Chander A.R., Guilarte T.R., Wong D.F., Sacktor N.C., et al. Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS. J Neurovirol 2005, 11:346-355.
6. Haris M., Cai K., Singh A., Hariharan H., Reddy R. In vivo mapping of brain myo-inositol. Neuroimage 2011, 54:2079-2085.
7. (1)H MRS study. Neurology 2001, 57:626-632.
8. Jones C.K., Schlosser M.J., van Zijl P.C., Pomper M.G., Golay X., Zhou J. Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med 2006, 56:585-592.
9. Kantarci K., Reynolds G., Petersen R.C., Boeve B.F., Knopman D.S., Edland S.D., et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3T. Am J Neuroradiol 2003, 24:843-849.
10. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu Rev Neurosci 2001, 24:1121-1159.
11. Ling W., Regatte R.R., Navon G., Jerschow A. Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci USA 2008, 105:2266-2270.
12. Marjanska M., Curran G.L., Wengenack T.M., Henry P.G., Bliss R.L., Poduslo J.F., et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 2005, 102:11906-11910.
13. Nagele R.G., Wegiel J., Venkataraman V., Imaki H., Wang K.C. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 2004, 25:663-674.
14. Nagy Z., Esiri M.M., Joachim C., Jobst K.A., Morris J.H., King E.M., et al. Comparison of pathological diagnostic criteria for Alzheimer disease. Alzheimer Dis Assoc Disord 1998, 12:182-189.
15. Petrella J.R., Coleman R.E., Doraiswamy P.M. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003, 226:315-336.
16. Sherry A.D., Woods M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng 2008, 10:391-411.
17. Siger M., Schuff N., Zhu X., Miller B.L., Weiner M.W. Regional myo-inositol concentration in mild cognitive impairment using 1H magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 2009, 23:57-62.
18. Streit W.J., Mrak R.E., Griffin W.S. Microglia and neuroinflammation: a pathological perspective. J Neuroinflamm 2004, 1:14.
19. Sun P.Z., Farrar C.T., Sorensen A.G. Correction for artifacts induced by B(0) and B(1) field inhomogeneities in pH-sensitive chemical exchange saturation transfer (CEST) imaging. Magn Reson Med 2007, 58:1207-1215.
20. van Zijl P.C., Jones C.K., Ren J., Malloy C.R., Sherry A.D. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci USA 2007, 104:4359-4364.
21. von Bernhardi R. Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 2007, 12:215-232.
22. Ward K.M., Aletras A.H., Balaban R.S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000, 143:79-87.
23. Ward K.M., Balaban R.S. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 2000, 44:799-802.
24. Winter P.M., Cai K., Chen J., Adair C.R., Kiefer G.E., Athey P.S., et al. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin. Magn Reson Med 2006, 56:1384-1388.
25. Zhou J., Payen J.F., Wilson D.A., Traystman R.J., van Zijl P.C. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003, 9:1085-1090.